Results 91 to 100 of about 25,924 (270)

Phenotypic Heterogeneity in Genetic and Acquired Pediatric Cerebellar Disorders

Movement Disorders, EarlyView.
Abstract Background The genetic landscape of pediatric cerebellar disorders (PCDs) in Finland is undefined. Objectives The objective was to define epidemiological, clinical, neuroradiological, and genetic characteristics of PCDs in Northern Finland.
Katariina Granath, Sanna Huhtaniska, Juulia Ellonen, Tytti Pokka, Salla M. Kangas, Jukka Moilanen, Heli Helander, Hanna Kallankari, Jonna Komulainen‐Ebrahim, Päivi Vieira, Elisa Rahikkala, Renzo Guerrini, Minna Honkila, Terhi S. Ruuska, Reetta Hinttala, Maria Suo‐Palosaari, Jussi‐Pekka Tolonen, Johanna Uusimaa   +17 more
wiley   +1 more source

Research Progress of Radial Extracorporeal Shock Wave Therapy for Post-Stroke Spasticity

康复学报
One of the common complications in stroke patients is muscle spasticity, which not only seriously affects the patient's motor ability, but can also may lead to sensory disturbance, persistent pain, muscle stiffness, reduced range of motion of the joints,
WU Zongqian, BAI Dingqun
doaj  

Adaptive Torque Control of Exoskeletons under Spasticity Conditions via Reinforcement Learning [PDF]

arXiv
Spasticity is a common movement disorder symptom in individuals with cerebral palsy, hereditary spastic paraplegia, spinal cord injury and stroke, being one of the most disabling features in the progression of these diseases. Despite the potential benefit of using wearable robots to treat spasticity, their use is not currently recommended to subjects ...
arxiv  

Emerging theory of sensitization in post-stroke muscle spasticity. [PDF]

Front Rehabil Sci, 2023
Suputtitada A.
europepmc   +1 more source

Development and Preliminary Validation of a Parkinsonism‐Dystonia Scale for Infants and Young Children

Movement Disorders, EarlyView.
Abstract Background Parkinsonism in infancy is rare and is highly correlated with the presence of dystonia. Advances in treating and characterizing developmental and infantile degenerative parkinsonism have highlighted the need for a specialized assessment scale.
Roser Pons, Toni S. Pearson, Belen Perez‐Dueñas, Angels Garcia‐Cazorla, Manju A. Kurian, Zoi Dalivigka, Vasiliki Zouvelou, Chrysa Outsika, Eleftheria Kokkinou, Maria Sigatullina‐Bondarenko, Alejandra Darling, Maria del Mar O'Callaghan, Robert Spaull, Dora B.D. Steel, Evdokia Salamou, Maria João Forjaz, Carmen Rodriguez‐Blazquez   +16 more
wiley   +1 more source

Evaluation of selective peripheral neurotomies in the treatment of refractory lower limb spasticity in adults

Alexandria Journal of Medicine, 2018
Background: “Selective peripheral neurotomies” (SPNs) are indicated for the treatment of refractory focal and multifocal spasticity of lower limbs in adults.
Sherif M. Salem, Waleed Fawzy El-Saadany, Wael Ahmed Fouad, Walid A. Abdel Ghany   +3 more
doaj  

Human Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series

EBioMedicine, 2016
Spasticity, muscle stiffness and contracture cause severe disability after central nervous system injury. However, current treatment options for spasticity produce muscle weakness which can impede movement, and do not directly address muscle stiffness ...
Preeti Raghavan, Ying Lu, Mona Mirchandani, Antonio Stecco   +3 more
doaj   +1 more source

A Systematic Review of Attributes Influencing Preferences for Treatments and Interventions in People With Amyotrophic Lateral Sclerosis (ALS)

Muscle &Nerve, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that has no cure, and treatments predominantly focus on improving quality of life. Patient‐centred care is central to bringing about meaningful improvements to quality of life.
A. Clift, D. Rowen, L. Knox, A. W. Griffiths, C. J. McDermott   +4 more
wiley   +1 more source

The use of botulinum toxin type A in the treatment of spasticity of the lower limbs in stroke patients. Clinical case

Нервно-мышечные болезни, 2015
The article describes a clinical case of spasticity and its treatment with botulinum toxin type A in a patient with the consequences of acute stroke.
A. P. Kovalenko
doaj   +1 more source

Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1

Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella, Costanza Masetti, Vidal Yahya, Mauro Treddenti, Gaia Oggioni, Tommaso Bocci, Laura Campiglio, Manuela Zardoni, Chiara Rosci, Marta Pengo, Chiara Manfredi, Roberto Del Bo, Edoardo Monfrini, Alessio Di Fonzo, Maurizio Inghilleri, Alberto Priori   +15 more
wiley   +1 more source